Evidence map›Paper›PMID 40613707›Full record

ArticleNucleic acids research2025

TRIP12's role in the governance of DNA polymerase β involvement in DNA damage response and repair.

Burcu Inanc, Qingming Fang, Wynand P Roos, Joel F Andrews, Xuemei Zeng, Jennifer Clark, Jianfeng Li, Nupur B Dey, Md Ibrahim, Peter Sykora and 8 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Poly-ADP-ribosylation dynamics, signaling, and analysis.Environmental and molecular mutagenesis · 2024
    Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Burcu InancDivision of Cell Biology, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.
Qingming FangMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.
Wynand P RoosDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School & Legorreta Cancer Center, Brown University, Providence, RI 02912, United States.ORCID 0000-0002-0474-7414
Joel F AndrewsMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.
Xuemei ZengBiomedical Mass Spectrometry Center, University of Pittsburgh, Pittsburgh, PA 15213, United States.
Jennifer ClarkMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.
Jianfeng LiMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.
Nupur B DeyMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.
Md IbrahimMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.
Peter SykoraMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.
Zhongxun YuDepartment of Medicine, Tsinghua University School of Medicine, Tsinghua University, Haidian District, Beijing 100084, China.
Charlotte R PearsonDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School & Legorreta Cancer Center, Brown University, Providence, RI 02912, United States.
Andrea BraganzaDepartment of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15213, United States.
Marcel VerheijDivision of Cell Biology, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.
Jos JonkersDivision of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.
Nathan A YatesBiomedical Mass Spectrometry Center, University of Pittsburgh, Pittsburgh, PA 15213, United States.
Conchita VensDivision of Cell Biology, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.
Robert W SobolMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, United States.ORCID 0000-0001-7385-3563

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
A Systems Approach to Mapping the DNA Damage ResponseR01ES014811 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2005 to 2021
$8.6M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparitiesR01CA238061 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI RAGIN, CAMILLE C., SOBOL, ROBERT W · 2019 to 2023
$3.4M
Measuring genomic DNA damage and DNA repair capacity in longitudinal population samples - a step towards precision preventionU01ES029518 · NIEHS · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2018 to 2022
$2.7M
Abraham A. Mitchell Distinguished InvestigatorBrown UniversityCRUK P30CA047904Dr. Robert Browning FoundationLegoretta Cancer Center Endowment FundNCI NIH HHS P30 CA047904NCI NIH HHS R01 CA148629NCI NIH HHS R01 CA238061Netherlands Cancer InstituteNIEHS NIH HHS R01 ES014811NIEHS NIH HHS U01 ES029518NIGMS NIH HHS P41 GM103504NIHNIH HHS CA148629NIH HHS CA238061NIH HHS ES014811NIH HHS ES029518the Dutch Cancer Society NKI-2010-4877USA MCI Core FacilityUSA MCI Flow Cytometry FacilityUSA Mitchell Cancer Institute (MCI) Cellular and Biomolecular Imaging Facility
6 · The paper itself

Abstract

The multitude of DNA lesion types, and the nuclear dynamic context in which they occur, presents a challenge for genome integrity maintenance as this requires the engagement of different DNA repair pathways. Specific "repair controllers" that facilitate DNA repair pathway crosstalk between double-strand break (DSB) repair and base excision repair (BER) and that regulate BER protein engagement at lesion sites have yet to be identified. Here, we find that DNA polymerase β (Polβ), crucial for BER, is ubiquitylated in a BER complex-dependent manner by TRIP12, an E3 ligase that partners with UBR5 to restrain DSB repair signaling. Furthermore, we find that TRIP12, but not UBR5, controls cellular levels and chromatin loading of Polβ. Required for Polβ foci formation, TRIP12 influences Polβ involvement after radiation-induced DNA damage, a process regulated by TRIP12-mediated ubiquitylation of Polβ. Notably, excessive TRIP12-mediated engagement of Polβ affects DSB formation and radiation sensitivity, underscoring its role in promoting precedence for BER over DSB repair. The herein discovered function of TRIP12, in the governance of Polβ-directed BER, supports a role for TRIP12 in assuring BER lesion removal at complex DSB sites to optimize DSB repair at the nexus of DNA repair pathways.

Indexed as

DNA DamageDNA Polymerase betaDNA RepairUbiquitin-Protein LigasesChromatinDNA Breaks, Double-StrandedHumansUbiquitinationChromatinDNA Polymerase betaUbiquitin-Protein LigasesUBR5 protein, human

Identifiers

PMID40613707
PMCPMC12231584

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.